Silence Therapeutics (SLNCF) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Silence Therapeutics (SLNCF) over the last 3 years, with Q3 2025 value amounting to $399000.0.
- Silence Therapeutics' Other Non-Current Assets fell 8567.68% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $399000.0, marking a year-over-year decrease of 8567.68%. This contributed to the annual value of $3.6 million for FY2024, which is 153.59% down from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Other Non-Current Assets is $399000.0, which was down 8567.68% from $3.9 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Non-Current Assets ranged from a high of $3.9 million in Q2 2025 and a low of $399000.0 during Q3 2025
- Over the past 3 years, Silence Therapeutics' median Other Non-Current Assets value was $3.2 million (recorded in 2023), while the average stood at $3.0 million.
- Within the past 5 years, the most significant YoY rise in Silence Therapeutics' Other Non-Current Assets was 3130.42% (2025), while the steepest drop was 8567.68% (2025).
- Quarter analysis of 3 years shows Silence Therapeutics' Other Non-Current Assets stood at $3.2 million in 2023, then rose by 12.11% to $3.6 million in 2024, then plummeted by 88.89% to $399000.0 in 2025.
- Its Other Non-Current Assets was $399000.0 in Q3 2025, compared to $3.9 million in Q2 2025 and $3.6 million in Q1 2025.